Alimera sciences reports third quarter 2023 results

Atlanta, oct. 26, 2023 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (“alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the third quarter of 2023. alimera will host a conference call today at 9:00 a.m. edt to discuss these results.
ALIM Ratings Summary
ALIM Quant Ranking